 David Ecker
Concepts (583)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrometry, Mass, Electrospray Ionization | 46 | 2019 | 179 | 4.220 |
Why?
| | Polymerase Chain Reaction | 50 | 2020 | 1054 | 3.200 |
Why?
| | Molecular Diagnostic Techniques | 11 | 2016 | 104 | 1.420 |
Why?
| | Biosensing Techniques | 5 | 2014 | 139 | 1.390 |
Why?
| | Bacteria | 13 | 2016 | 889 | 1.000 |
Why?
| | Microbiological Techniques | 6 | 2013 | 33 | 0.990 |
Why?
| | DNA, Bacterial | 19 | 2016 | 342 | 0.940 |
Why?
| | Lyme Disease | 6 | 2020 | 58 | 0.930 |
Why?
| | Ixodes | 5 | 2017 | 12 | 0.810 |
Why?
| | Biohazard Release | 1 | 2023 | 1 | 0.800 |
Why?
| | Communicable Diseases, Emerging | 4 | 2008 | 38 | 0.790 |
Why?
| | Biological Warfare Agents | 2 | 2013 | 3 | 0.780 |
Why?
| | Disease Outbreaks | 5 | 2023 | 422 | 0.760 |
Why?
| | Viruses | 6 | 2012 | 165 | 0.730 |
Why?
| | Genotype | 22 | 2019 | 1835 | 0.720 |
Why?
| | Blood | 5 | 2016 | 109 | 0.700 |
Why?
| | Bacterial Typing Techniques | 12 | 2013 | 44 | 0.660 |
Why?
| | Sensitivity and Specificity | 19 | 2023 | 1990 | 0.640 |
Why?
| | Borrelia burgdorferi | 5 | 2020 | 21 | 0.640 |
Why?
| | Clinical Competence | 2 | 2018 | 1244 | 0.620 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 8 | 2013 | 983 | 0.610 |
Why?
| | Bacteremia | 6 | 2015 | 221 | 0.610 |
Why?
| | Drug Design | 5 | 2008 | 173 | 0.590 |
Why?
| | Licensure, Medical | 1 | 2018 | 18 | 0.550 |
Why?
| | Physician Executives | 1 | 2018 | 28 | 0.540 |
Why?
| | Delivery of Health Care | 1 | 2024 | 947 | 0.500 |
Why?
| | Mass Spectrometry | 11 | 2014 | 750 | 0.490 |
Why?
| | Escherichia coli | 14 | 2015 | 855 | 0.490 |
Why?
| | Base Sequence | 30 | 2012 | 2191 | 0.480 |
Why?
| | Population Surveillance | 3 | 2009 | 485 | 0.470 |
Why?
| | Anaplasmataceae | 1 | 2015 | 1 | 0.470 |
Why?
| | DNA Primers | 14 | 2012 | 512 | 0.440 |
Why?
| | Educational Measurement | 1 | 2018 | 326 | 0.440 |
Why?
| | Virus Diseases | 5 | 2014 | 216 | 0.430 |
Why?
| | Hospitals | 2 | 2023 | 732 | 0.430 |
Why?
| | DNA, Fungal | 3 | 2014 | 83 | 0.420 |
Why?
| | Bacteriological Techniques | 6 | 2016 | 68 | 0.410 |
Why?
| | Candida | 2 | 2013 | 44 | 0.410 |
Why?
| | Civil Defense | 1 | 2013 | 21 | 0.400 |
Why?
| | Communicable Diseases | 2 | 2013 | 163 | 0.400 |
Why?
| | Acinetobacter baumannii | 6 | 2012 | 24 | 0.390 |
Why?
| | RNA, Viral | 8 | 2010 | 688 | 0.380 |
Why?
| | Molecular Sequence Data | 25 | 2014 | 2931 | 0.360 |
Why?
| | Biodiversity | 1 | 2015 | 426 | 0.350 |
Why?
| | Oligodeoxyribonucleotides | 5 | 1998 | 141 | 0.350 |
Why?
| | Thionucleotides | 5 | 1998 | 35 | 0.340 |
Why?
| | Point-of-Care Systems | 1 | 2013 | 187 | 0.340 |
Why?
| | Borrelia | 5 | 2014 | 9 | 0.340 |
Why?
| | Influenza A virus | 3 | 2011 | 113 | 0.330 |
Why?
| | Respiratory Tract Infections | 4 | 2011 | 398 | 0.330 |
Why?
| | Acinetobacter Infections | 6 | 2012 | 13 | 0.320 |
Why?
| | Fungemia | 1 | 2010 | 10 | 0.320 |
Why?
| | Molecular Epidemiology | 3 | 2010 | 73 | 0.320 |
Why?
| | Humans | 86 | 2024 | 144957 | 0.320 |
Why?
| | Anti-Bacterial Agents | 7 | 2019 | 1915 | 0.310 |
Why?
| | Computer Simulation | 6 | 2023 | 1026 | 0.300 |
Why?
| | Cross Infection | 3 | 2010 | 262 | 0.300 |
Why?
| | Rickettsia | 4 | 2017 | 11 | 0.300 |
Why?
| | Acinetobacter | 4 | 2013 | 16 | 0.290 |
Why?
| | Genetics, Microbial | 1 | 2009 | 11 | 0.290 |
Why?
| | Biological Products | 2 | 2009 | 252 | 0.280 |
Why?
| | Adenoviridae | 2 | 2011 | 199 | 0.270 |
Why?
| | Ubiquitins | 9 | 1994 | 33 | 0.270 |
Why?
| | Drug Discovery | 1 | 2009 | 155 | 0.270 |
Why?
| | Adenoviridae Infections | 1 | 2007 | 20 | 0.270 |
Why?
| | Oligonucleotides, Antisense | 6 | 1993 | 116 | 0.260 |
Why?
| | Fungi | 6 | 2013 | 161 | 0.260 |
Why?
| | Culex | 1 | 2007 | 14 | 0.260 |
Why?
| | Alphavirus | 1 | 2007 | 22 | 0.260 |
Why?
| | Staphylococcus aureus | 7 | 2014 | 460 | 0.260 |
Why?
| | Environmental Microbiology | 1 | 2007 | 57 | 0.260 |
Why?
| | Nucleic Acid Conformation | 12 | 2005 | 726 | 0.260 |
Why?
| | Bacterial Infections | 5 | 2014 | 246 | 0.260 |
Why?
| | Bioterrorism | 3 | 2008 | 31 | 0.250 |
Why?
| | HIV-1 | 6 | 2002 | 896 | 0.250 |
Why?
| | Aedes | 1 | 2007 | 65 | 0.250 |
Why?
| | Antibody Formation | 1 | 2008 | 294 | 0.250 |
Why?
| | Base Composition | 6 | 2012 | 82 | 0.240 |
Why?
| | Microbial Sensitivity Tests | 6 | 2015 | 371 | 0.240 |
Why?
| | Animals | 37 | 2017 | 38109 | 0.240 |
Why?
| | Sequence Alignment | 3 | 2010 | 368 | 0.240 |
Why?
| | Klebsiella pneumoniae | 3 | 2015 | 47 | 0.230 |
Why?
| | 5' Untranslated Regions | 2 | 2004 | 59 | 0.230 |
Why?
| | Coronaviridae Infections | 1 | 2005 | 3 | 0.220 |
Why?
| | Coronaviridae | 1 | 2005 | 4 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2023 | 550 | 0.220 |
Why?
| | Sentinel Surveillance | 1 | 2005 | 46 | 0.220 |
Why?
| | DNA, Viral | 6 | 2014 | 358 | 0.220 |
Why?
| | RNA | 10 | 2010 | 940 | 0.220 |
Why?
| | Chromosome Mapping | 2 | 2004 | 510 | 0.220 |
Why?
| | Tick-Borne Diseases | 3 | 2020 | 11 | 0.210 |
Why?
| | Antiviral Agents | 4 | 1994 | 768 | 0.210 |
Why?
| | Oligonucleotides | 4 | 1997 | 151 | 0.210 |
Why?
| | Candidemia | 2 | 2014 | 15 | 0.200 |
Why?
| | Databases, Factual | 3 | 2008 | 1486 | 0.200 |
Why?
| | Virulence Factors | 1 | 2005 | 174 | 0.200 |
Why?
| | Drug Resistance, Bacterial | 5 | 2013 | 199 | 0.200 |
Why?
| | beta-Lactam Resistance | 2 | 2015 | 9 | 0.200 |
Why?
| | Pharmacology | 1 | 2003 | 11 | 0.190 |
Why?
| | Symbiosis | 2 | 2015 | 81 | 0.190 |
Why?
| | Gene Products, rev | 1 | 2002 | 6 | 0.190 |
Why?
| | Embryonic Development | 1 | 2004 | 125 | 0.190 |
Why?
| | Mycoses | 4 | 2014 | 88 | 0.190 |
Why?
| | Lentivirus | 1 | 2002 | 60 | 0.190 |
Why?
| | Genes, Bacterial | 5 | 2013 | 166 | 0.190 |
Why?
| | Response Elements | 1 | 2002 | 89 | 0.180 |
Why?
| | Faculty | 1 | 2023 | 149 | 0.180 |
Why?
| | Schools, Medical | 1 | 2023 | 157 | 0.180 |
Why?
| | Staphylococcal Infections | 3 | 2014 | 390 | 0.180 |
Why?
| | Virology | 2 | 2013 | 36 | 0.180 |
Why?
| | Saccharomyces cerevisiae | 10 | 1994 | 579 | 0.180 |
Why?
| | Sequence Analysis, RNA | 1 | 2004 | 442 | 0.180 |
Why?
| | Oligoribonucleotides | 2 | 1992 | 52 | 0.180 |
Why?
| | Transcription, Genetic | 5 | 2001 | 1496 | 0.180 |
Why?
| | Algorithms | 5 | 2011 | 1839 | 0.180 |
Why?
| | Flaviviridae | 1 | 2001 | 10 | 0.170 |
Why?
| | Health Equity | 1 | 2024 | 129 | 0.170 |
Why?
| | Central Nervous System Infections | 2 | 2012 | 35 | 0.170 |
Why?
| | Borrelia burgdorferi Group | 1 | 2020 | 7 | 0.170 |
Why?
| | Gene Expression Regulation | 7 | 2004 | 2609 | 0.160 |
Why?
| | Babesia | 2 | 2017 | 3 | 0.160 |
Why?
| | Anaplasma phagocytophilum | 2 | 2017 | 3 | 0.160 |
Why?
| | Tuberculosis, Multidrug-Resistant | 2 | 2011 | 50 | 0.160 |
Why?
| | Antineoplastic Agents | 2 | 2009 | 2197 | 0.160 |
Why?
| | HIV | 2 | 1992 | 250 | 0.160 |
Why?
| | Behavior, Animal | 1 | 2004 | 520 | 0.160 |
Why?
| | HIV-2 | 2 | 2002 | 18 | 0.160 |
Why?
| | Benzoates | 1 | 1999 | 50 | 0.150 |
Why?
| | California | 2 | 2015 | 475 | 0.150 |
Why?
| | Genetic Techniques | 2 | 2005 | 67 | 0.150 |
Why?
| | Metallothionein | 8 | 1994 | 25 | 0.140 |
Why?
| | Sepsis | 2 | 2016 | 641 | 0.140 |
Why?
| | Streptococcus pneumoniae | 2 | 2012 | 177 | 0.140 |
Why?
| | Ribosomes | 3 | 2005 | 191 | 0.140 |
Why?
| | Sequence Analysis, DNA | 4 | 2015 | 824 | 0.140 |
Why?
| | Streptococcal Infections | 2 | 2012 | 169 | 0.140 |
Why?
| | Quinazolines | 1 | 1999 | 266 | 0.140 |
Why?
| | Tick Infestations | 1 | 2017 | 5 | 0.130 |
Why?
| | RNA, Bacterial | 6 | 2013 | 189 | 0.130 |
Why?
| | Cell Fusion | 2 | 1994 | 49 | 0.130 |
Why?
| | HIV Envelope Protein gp120 | 2 | 1994 | 55 | 0.130 |
Why?
| | Pneumonia, Bacterial | 2 | 2015 | 113 | 0.130 |
Why?
| | Evolution, Molecular | 3 | 2012 | 515 | 0.130 |
Why?
| | Communicable Disease Control | 2 | 2008 | 86 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2024 | 728 | 0.130 |
Why?
| | Glossitis, Benign Migratory | 2 | 2013 | 5 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2012 | 2147 | 0.120 |
Why?
| | Ticks | 3 | 2012 | 29 | 0.120 |
Why?
| | Structure-Activity Relationship | 5 | 1999 | 570 | 0.120 |
Why?
| | Specimen Handling | 2 | 2015 | 186 | 0.120 |
Why?
| | Klebsiella Infections | 2 | 2010 | 26 | 0.120 |
Why?
| | Blood-Borne Pathogens | 1 | 2015 | 7 | 0.120 |
Why?
| | Drug Evaluation, Preclinical | 4 | 1997 | 194 | 0.120 |
Why?
| | Nucleosides | 1 | 1995 | 25 | 0.120 |
Why?
| | Chemistry, Pharmaceutical | 2 | 1995 | 109 | 0.110 |
Why?
| | Enterobacteriaceae Infections | 1 | 2015 | 41 | 0.110 |
Why?
| | Phylogeny | 3 | 2015 | 1019 | 0.110 |
Why?
| | Cluster Analysis | 3 | 2012 | 521 | 0.110 |
Why?
| | Models, Biological | 1 | 2003 | 1822 | 0.110 |
Why?
| | Models, Chemical | 2 | 1996 | 269 | 0.110 |
Why?
| | Simplexvirus | 2 | 1993 | 82 | 0.110 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 97 | 0.110 |
Why?
| | Species Specificity | 4 | 2012 | 574 | 0.110 |
Why?
| | Streptococcus pyogenes | 2 | 2009 | 41 | 0.110 |
Why?
| | Babesia microti | 1 | 2014 | 1 | 0.110 |
Why?
| | Health Care Reform | 1 | 2015 | 110 | 0.110 |
Why?
| | Conserved Sequence | 2 | 2005 | 245 | 0.110 |
Why?
| | Genes, Fungal | 4 | 1994 | 55 | 0.110 |
Why?
| | Carbapenems | 2 | 2013 | 26 | 0.100 |
Why?
| | Statistics as Topic | 2 | 2012 | 284 | 0.100 |
Why?
| | Hand, Foot and Mouth Disease | 1 | 2013 | 3 | 0.100 |
Why?
| | Serologic Tests | 1 | 2013 | 53 | 0.100 |
Why?
| | Multilocus Sequence Typing | 1 | 2013 | 17 | 0.100 |
Why?
| | Mastitis, Bovine | 1 | 2013 | 2 | 0.100 |
Why?
| | Europe | 4 | 2016 | 412 | 0.100 |
Why?
| | Venous Thrombosis | 1 | 2015 | 195 | 0.100 |
Why?
| | Aza Compounds | 1 | 2013 | 13 | 0.100 |
Why?
| | Povidone-Iodine | 1 | 2013 | 11 | 0.100 |
Why?
| | Neoplasms | 1 | 2009 | 2884 | 0.100 |
Why?
| | Mycology | 1 | 2013 | 5 | 0.100 |
Why?
| | Bacterial Proteins | 5 | 2011 | 962 | 0.100 |
Why?
| | Pulmonary Embolism | 1 | 2015 | 244 | 0.100 |
Why?
| | Enterovirus | 1 | 2013 | 82 | 0.100 |
Why?
| | Streptococcus intermedius | 1 | 2012 | 1 | 0.100 |
Why?
| | Genes | 3 | 1989 | 226 | 0.100 |
Why?
| | Fusion Proteins, gag-pol | 1 | 1992 | 2 | 0.090 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 2313 | 0.090 |
Why?
| | DNA | 7 | 2010 | 1464 | 0.090 |
Why?
| | Frameshift Mutation | 1 | 1992 | 32 | 0.090 |
Why?
| | Eye Infections, Bacterial | 1 | 2013 | 44 | 0.090 |
Why?
| | Dirofilariasis | 1 | 2012 | 1 | 0.090 |
Why?
| | Ixodidae | 1 | 2012 | 7 | 0.090 |
Why?
| | Infection Control | 1 | 2014 | 172 | 0.090 |
Why?
| | False Negative Reactions | 1 | 2012 | 61 | 0.090 |
Why?
| | Milk | 1 | 2013 | 119 | 0.090 |
Why?
| | Francisella tularensis | 1 | 2012 | 33 | 0.090 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2013 | 70 | 0.090 |
Why?
| | Diarrhea | 1 | 2013 | 192 | 0.090 |
Why?
| | Limit of Detection | 1 | 2012 | 97 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 1995 | 826 | 0.090 |
Why?
| | Antitubercular Agents | 2 | 2011 | 216 | 0.090 |
Why?
| | RNA, Antisense | 1 | 1991 | 18 | 0.090 |
Why?
| | Research Report | 1 | 2012 | 87 | 0.090 |
Why?
| | Biological Assay | 1 | 2012 | 128 | 0.090 |
Why?
| | Prostheses and Implants | 1 | 2013 | 141 | 0.090 |
Why?
| | Virus Replication | 5 | 2005 | 529 | 0.090 |
Why?
| | RNA Caps | 1 | 1991 | 33 | 0.090 |
Why?
| | Quinolines | 1 | 2013 | 193 | 0.090 |
Why?
| | HIV Long Terminal Repeat | 1 | 1991 | 11 | 0.090 |
Why?
| | Xenotropic murine leukemia virus-related virus | 1 | 2011 | 1 | 0.090 |
Why?
| | Dog Diseases | 1 | 2012 | 70 | 0.090 |
Why?
| | Serotyping | 2 | 2008 | 32 | 0.090 |
Why?
| | Molecular Typing | 1 | 2011 | 21 | 0.090 |
Why?
| | Nucleic Acids | 1 | 2012 | 72 | 0.090 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2011 | 19 | 0.080 |
Why?
| | Hospitals, Military | 2 | 2008 | 31 | 0.080 |
Why?
| | Thermodynamics | 6 | 2002 | 426 | 0.080 |
Why?
| | Signal Transduction | 1 | 2004 | 5233 | 0.080 |
Why?
| | Mycoplasma | 1 | 2010 | 5 | 0.080 |
Why?
| | Nasopharynx | 1 | 2011 | 73 | 0.080 |
Why?
| | Helicobacter | 1 | 2010 | 3 | 0.080 |
Why?
| | Disease Vectors | 1 | 2010 | 15 | 0.080 |
Why?
| | Pyoderma Gangrenosum | 1 | 2010 | 8 | 0.080 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2010 | 39 | 0.080 |
Why?
| | Enterobacteriaceae | 1 | 2010 | 43 | 0.080 |
Why?
| | Male | 20 | 2016 | 72406 | 0.080 |
Why?
| | Helicobacter Infections | 1 | 2010 | 30 | 0.080 |
Why?
| | Mutation | 5 | 1996 | 4099 | 0.080 |
Why?
| | Ehrlichia | 1 | 2009 | 4 | 0.080 |
Why?
| | Flavivirus | 1 | 2010 | 19 | 0.080 |
Why?
| | Agammaglobulinemia | 1 | 2010 | 36 | 0.080 |
Why?
| | beta-Lactamases | 1 | 2010 | 51 | 0.080 |
Why?
| | Ehrlichiosis | 1 | 2009 | 4 | 0.080 |
Why?
| | Feces | 1 | 2013 | 513 | 0.080 |
Why?
| | Medicare | 1 | 2015 | 887 | 0.080 |
Why?
| | Orthopoxvirus | 1 | 2009 | 4 | 0.080 |
Why?
| | Middle Aged | 14 | 2016 | 35928 | 0.080 |
Why?
| | Military Personnel | 3 | 2006 | 747 | 0.080 |
Why?
| | Protozoan Infections | 2 | 2008 | 11 | 0.070 |
Why?
| | Female | 20 | 2016 | 78376 | 0.070 |
Why?
| | Mycobacterium | 1 | 2010 | 116 | 0.070 |
Why?
| | Time Factors | 5 | 2015 | 7183 | 0.070 |
Why?
| | Nucleic Acid Hybridization | 6 | 1996 | 187 | 0.070 |
Why?
| | Yeasts | 2 | 2013 | 52 | 0.070 |
Why?
| | Peptide Library | 3 | 1999 | 95 | 0.070 |
Why?
| | Metals | 2 | 1986 | 142 | 0.070 |
Why?
| | Monte Carlo Method | 4 | 1997 | 155 | 0.070 |
Why?
| | Disulfides | 1 | 1989 | 96 | 0.070 |
Why?
| | Young Adult | 7 | 2016 | 14126 | 0.070 |
Why?
| | Eukaryota | 2 | 2008 | 60 | 0.070 |
Why?
| | Adult | 15 | 2016 | 40506 | 0.070 |
Why?
| | Thalassemia | 1 | 2008 | 6 | 0.070 |
Why?
| | Porifera | 1 | 2008 | 8 | 0.070 |
Why?
| | Marine Toxins | 1 | 2008 | 12 | 0.070 |
Why?
| | Chlamydiales | 1 | 2007 | 1 | 0.070 |
Why?
| | Campylobacter | 1 | 2008 | 10 | 0.070 |
Why?
| | Receptor, IGF Type 1 | 1 | 2008 | 64 | 0.070 |
Why?
| | United States | 6 | 2018 | 15988 | 0.070 |
Why?
| | Computational Biology | 2 | 2002 | 681 | 0.070 |
Why?
| | Pneumococcal Infections | 1 | 2008 | 103 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 2011 | 337 | 0.070 |
Why?
| | Warfare | 1 | 2008 | 101 | 0.060 |
Why?
| | Aged | 9 | 2016 | 25947 | 0.060 |
Why?
| | Adolescent | 11 | 2016 | 22453 | 0.060 |
Why?
| | Infant | 5 | 2013 | 10039 | 0.060 |
Why?
| | Adenovirus Infections, Human | 1 | 2006 | 15 | 0.060 |
Why?
| | Cancer Vaccines | 1 | 2008 | 160 | 0.060 |
Why?
| | Adenoviruses, Human | 1 | 2006 | 26 | 0.060 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2013 | 559 | 0.060 |
Why?
| | Quinolones | 1 | 2009 | 201 | 0.060 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2001 | 96 | 0.060 |
Why?
| | Genome, Bacterial | 2 | 2012 | 156 | 0.060 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2006 | 81 | 0.060 |
Why?
| | Pharmaceutical Preparations | 1 | 2008 | 170 | 0.060 |
Why?
| | RNA Interference | 1 | 2008 | 476 | 0.060 |
Why?
| | Neuropeptides | 1 | 2006 | 77 | 0.060 |
Why?
| | Plasmids | 5 | 1992 | 379 | 0.060 |
Why?
| | Child, Preschool | 5 | 2013 | 11799 | 0.060 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2005 | 20 | 0.060 |
Why?
| | Prevalence | 4 | 2014 | 2836 | 0.060 |
Why?
| | Forensic Sciences | 1 | 2005 | 6 | 0.060 |
Why?
| | Phospholipases A | 2 | 1996 | 98 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2008 | 233 | 0.060 |
Why?
| | Mice | 9 | 2017 | 18365 | 0.060 |
Why?
| | Huntington Disease | 1 | 2006 | 61 | 0.060 |
Why?
| | DNA Fingerprinting | 3 | 2010 | 32 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 5 | 1992 | 675 | 0.060 |
Why?
| | Binding Sites | 4 | 2005 | 1331 | 0.060 |
Why?
| | Aged, 80 and over | 6 | 2016 | 8279 | 0.050 |
Why?
| | Early Diagnosis | 2 | 2016 | 249 | 0.050 |
Why?
| | Genetic Variation | 1 | 2010 | 984 | 0.050 |
Why?
| | Prospective Studies | 5 | 2016 | 7997 | 0.050 |
Why?
| | Bacillus anthracis | 1 | 2004 | 13 | 0.050 |
Why?
| | Genotyping Techniques | 2 | 2015 | 69 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2005 | 93 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2005 | 190 | 0.050 |
Why?
| | Protein Precursors | 2 | 1999 | 137 | 0.050 |
Why?
| | Kinetics | 9 | 1999 | 1629 | 0.050 |
Why?
| | DNA, Mitochondrial | 1 | 2005 | 212 | 0.050 |
Why?
| | Hepacivirus | 1 | 2005 | 243 | 0.050 |
Why?
| | Maze Learning | 1 | 2004 | 104 | 0.050 |
Why?
| | Videotape Recording | 1 | 2023 | 37 | 0.050 |
Why?
| | RNA, Ribosomal | 2 | 2001 | 168 | 0.050 |
Why?
| | Amino Acid Sequence | 5 | 1992 | 2157 | 0.050 |
Why?
| | Chemistry | 1 | 2003 | 41 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 460 | 0.050 |
Why?
| | Chemical Phenomena | 1 | 2003 | 81 | 0.050 |
Why?
| | rev Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 6 | 0.050 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2002 | 18 | 0.050 |
Why?
| | Polyethylene Glycols | 1 | 2008 | 655 | 0.050 |
Why?
| | Child | 6 | 2013 | 22657 | 0.050 |
Why?
| | Genomics | 1 | 2008 | 836 | 0.050 |
Why?
| | Recombinant Proteins | 4 | 2006 | 1371 | 0.050 |
Why?
| | Writing | 1 | 2023 | 100 | 0.050 |
Why?
| | Gene Products, tat | 2 | 1992 | 22 | 0.040 |
Why?
| | Animals, Genetically Modified | 1 | 2003 | 250 | 0.040 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 2 | 1992 | 25 | 0.040 |
Why?
| | Antibodies, Bacterial | 2 | 2013 | 148 | 0.040 |
Why?
| | Rho Factor | 1 | 2001 | 4 | 0.040 |
Why?
| | Primates | 1 | 2002 | 132 | 0.040 |
Why?
| | Cerebrospinal Fluid | 2 | 2012 | 88 | 0.040 |
Why?
| | Educational Status | 1 | 2023 | 467 | 0.040 |
Why?
| | Minisatellite Repeats | 2 | 2012 | 36 | 0.040 |
Why?
| | Cell Line | 3 | 2005 | 2882 | 0.040 |
Why?
| | Ohio | 2 | 2012 | 145 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1524 | 0.040 |
Why?
| | Models, Molecular | 1 | 2005 | 1619 | 0.040 |
Why?
| | RNA, Transfer | 1 | 2001 | 144 | 0.040 |
Why?
| | Encephalitis Viruses, Tick-Borne | 2 | 2010 | 8 | 0.040 |
Why?
| | Reproducibility of Results | 3 | 2013 | 3415 | 0.040 |
Why?
| | Point Mutation | 2 | 2009 | 243 | 0.040 |
Why?
| | RNA, Ribosomal, 18S | 1 | 1999 | 27 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 1999 | 113 | 0.040 |
Why?
| | Enterococcus faecalis | 1 | 1999 | 29 | 0.040 |
Why?
| | Forecasting | 1 | 2001 | 391 | 0.040 |
Why?
| | Critical Illness | 2 | 2016 | 892 | 0.040 |
Why?
| | Splanchnic Circulation | 1 | 1999 | 13 | 0.040 |
Why?
| | Extracorporeal Circulation | 1 | 1999 | 15 | 0.040 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 2 | 2009 | 23 | 0.040 |
Why?
| | Calcitonin | 1 | 1999 | 27 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 1999 | 131 | 0.040 |
Why?
| | Protein Biosynthesis | 2 | 1999 | 458 | 0.030 |
Why?
| | Genetic Markers | 2 | 2012 | 331 | 0.030 |
Why?
| | Mutation, Missense | 2 | 2011 | 340 | 0.030 |
Why?
| | Artiodactyla | 1 | 2017 | 2 | 0.030 |
Why?
| | Czech Republic | 1 | 2017 | 4 | 0.030 |
Why?
| | RNA, Messenger | 5 | 1994 | 2832 | 0.030 |
Why?
| | Sus scrofa | 1 | 2017 | 64 | 0.030 |
Why?
| | Deer | 1 | 2017 | 34 | 0.030 |
Why?
| | Arvicolinae | 1 | 2017 | 32 | 0.030 |
Why?
| | Auranofin | 2 | 1987 | 6 | 0.030 |
Why?
| | Birds | 1 | 2017 | 92 | 0.030 |
Why?
| | Risk Assessment | 2 | 2016 | 3676 | 0.030 |
Why?
| | GTP-Binding Proteins | 2 | 1994 | 153 | 0.030 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1996 | 73 | 0.030 |
Why?
| | Anxiety | 1 | 2004 | 1110 | 0.030 |
Why?
| | HeLa Cells | 3 | 1993 | 650 | 0.030 |
Why?
| | Sciuridae | 1 | 2017 | 152 | 0.030 |
Why?
| | Receptors, Leukotriene B4 | 1 | 1995 | 7 | 0.030 |
Why?
| | Endopeptidases | 3 | 1994 | 82 | 0.030 |
Why?
| | Leukotriene B4 | 1 | 1995 | 37 | 0.030 |
Why?
| | Gram-Positive Bacteria | 1 | 2015 | 47 | 0.030 |
Why?
| | Binding, Competitive | 1 | 1995 | 193 | 0.030 |
Why?
| | Body Fluids | 1 | 2015 | 70 | 0.030 |
Why?
| | Esters | 1 | 1995 | 78 | 0.030 |
Why?
| | Gram-Negative Bacteria | 1 | 2015 | 81 | 0.030 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 1993 | 253 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1994 | 16 | 0.030 |
Why?
| | Biotechnology | 1 | 1995 | 46 | 0.030 |
Why?
| | Arthropod Vectors | 1 | 2014 | 7 | 0.030 |
Why?
| | Adenylyl Cyclases | 1 | 1994 | 60 | 0.030 |
Why?
| | Automation, Laboratory | 1 | 2014 | 7 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1995 | 224 | 0.030 |
Why?
| | Zidovudine | 1 | 1994 | 77 | 0.030 |
Why?
| | Mupirocin | 1 | 2014 | 7 | 0.030 |
Why?
| | Germany | 1 | 2014 | 138 | 0.030 |
Why?
| | Methicillin Resistance | 1 | 2014 | 17 | 0.030 |
Why?
| | Maryland | 1 | 2014 | 66 | 0.030 |
Why?
| | Fungal Proteins | 1 | 1994 | 145 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 2032 | 0.030 |
Why?
| | Tritium | 1 | 1993 | 68 | 0.030 |
Why?
| | Amplified Fragment Length Polymorphism Analysis | 1 | 2013 | 1 | 0.020 |
Why?
| | Nose | 1 | 2014 | 68 | 0.020 |
Why?
| | Bangladesh | 1 | 2013 | 62 | 0.020 |
Why?
| | Arizona | 1 | 2013 | 81 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1385 | 0.020 |
Why?
| | Africa | 1 | 2013 | 116 | 0.020 |
Why?
| | Fluoroquinolones | 1 | 2013 | 45 | 0.020 |
Why?
| | Anti-Infective Agents, Local | 1 | 2013 | 40 | 0.020 |
Why?
| | Virulence | 1 | 1994 | 280 | 0.020 |
Why?
| | Gene Library | 1 | 1993 | 126 | 0.020 |
Why?
| | Endophthalmitis | 1 | 2013 | 45 | 0.020 |
Why?
| | Corneal Diseases | 1 | 2013 | 46 | 0.020 |
Why?
| | Brain Abscess | 1 | 2012 | 10 | 0.020 |
Why?
| | Cattle | 2 | 2013 | 1000 | 0.020 |
Why?
| | Nymph | 1 | 2012 | 4 | 0.020 |
Why?
| | Rabbits | 2 | 2009 | 648 | 0.020 |
Why?
| | Reticulocytes | 2 | 1989 | 17 | 0.020 |
Why?
| | Cloning, Molecular | 3 | 1989 | 541 | 0.020 |
Why?
| | Genes, ras | 1 | 1992 | 96 | 0.020 |
Why?
| | Ovum | 1 | 2012 | 31 | 0.020 |
Why?
| | Tularemia | 1 | 2012 | 30 | 0.020 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 99 | 0.020 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2010 | 61 | 0.020 |
Why?
| | DNA, Ribosomal | 1 | 2012 | 94 | 0.020 |
Why?
| | Iron | 2 | 2002 | 359 | 0.020 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1992 | 94 | 0.020 |
Why?
| | Ribonuclease H | 1 | 1991 | 12 | 0.020 |
Why?
| | Nucleic Acid Denaturation | 1 | 1991 | 32 | 0.020 |
Why?
| | Microbial Viability | 1 | 2012 | 90 | 0.020 |
Why?
| | Antibiotic Prophylaxis | 1 | 2013 | 129 | 0.020 |
Why?
| | Ligases | 2 | 1989 | 37 | 0.020 |
Why?
| | Adenosine | 1 | 1993 | 255 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 1989 | 631 | 0.020 |
Why?
| | Parainfluenza Virus 2, Human | 1 | 2011 | 3 | 0.020 |
Why?
| | Parainfluenza Virus 3, Human | 1 | 2011 | 5 | 0.020 |
Why?
| | Larva | 1 | 2012 | 242 | 0.020 |
Why?
| | Cell Cycle | 1 | 1994 | 597 | 0.020 |
Why?
| | Georgia (Republic) | 1 | 2010 | 4 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 331 | 0.020 |
Why?
| | Endemic Diseases | 1 | 2011 | 33 | 0.020 |
Why?
| | Influenza B virus | 1 | 2011 | 47 | 0.020 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2011 | 34 | 0.020 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2011 | 58 | 0.020 |
Why?
| | Dogs | 1 | 2012 | 438 | 0.020 |
Why?
| | New York City | 1 | 2010 | 89 | 0.020 |
Why?
| | Anti-HIV Agents | 1 | 1998 | 888 | 0.020 |
Why?
| | Pregnancy | 1 | 2004 | 7191 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 1991 | 145 | 0.020 |
Why?
| | Peptide Fragments | 1 | 1994 | 699 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 249 | 0.020 |
Why?
| | Phenotype | 2 | 2009 | 3164 | 0.020 |
Why?
| | Rifampin | 1 | 2010 | 82 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2011 | 246 | 0.020 |
Why?
| | Liver | 1 | 1999 | 1888 | 0.020 |
Why?
| | China | 1 | 2011 | 269 | 0.020 |
Why?
| | Flavivirus Infections | 1 | 2010 | 9 | 0.020 |
Why?
| | Isoniazid | 1 | 2010 | 71 | 0.020 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2010 | 25 | 0.020 |
Why?
| | Culicidae | 1 | 2010 | 33 | 0.020 |
Why?
| | Rickettsia rickettsii | 1 | 2009 | 1 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1048 | 0.020 |
Why?
| | DNA, Protozoan | 1 | 2010 | 32 | 0.020 |
Why?
| | Water | 1 | 1993 | 469 | 0.020 |
Why?
| | Neisseria meningitidis | 1 | 2009 | 23 | 0.020 |
Why?
| | West Nile virus | 1 | 2010 | 41 | 0.020 |
Why?
| | RNA, Protozoan | 1 | 2010 | 60 | 0.020 |
Why?
| | South Africa | 1 | 2010 | 261 | 0.020 |
Why?
| | Geography | 1 | 2010 | 203 | 0.020 |
Why?
| | Dengue Virus | 1 | 2010 | 58 | 0.020 |
Why?
| | Critical Care | 1 | 2015 | 697 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2010 | 127 | 0.020 |
Why?
| | DNA Topoisomerase IV | 1 | 2009 | 1 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2009 | 157 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2015 | 916 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2013 | 6434 | 0.020 |
Why?
| | North America | 1 | 2010 | 310 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 1991 | 383 | 0.020 |
Why?
| | DNA Gyrase | 1 | 2009 | 12 | 0.020 |
Why?
| | Cystine | 1 | 1989 | 18 | 0.020 |
Why?
| | Genetic Vectors | 2 | 1988 | 337 | 0.020 |
Why?
| | Bacterial Toxins | 1 | 2009 | 110 | 0.020 |
Why?
| | Genetic Loci | 1 | 2010 | 261 | 0.020 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1989 | 61 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1495 | 0.020 |
Why?
| | Molecular Weight | 4 | 1990 | 327 | 0.020 |
Why?
| | Cells, Cultured | 2 | 1994 | 4155 | 0.020 |
Why?
| | Forensic Medicine | 1 | 2008 | 17 | 0.020 |
Why?
| | Government Agencies | 1 | 2008 | 14 | 0.020 |
Why?
| | Multigene Family | 1 | 1989 | 204 | 0.020 |
Why?
| | Temperature | 1 | 1991 | 679 | 0.020 |
Why?
| | Campylobacter coli | 1 | 2008 | 1 | 0.020 |
Why?
| | Protein Binding | 1 | 1994 | 2276 | 0.020 |
Why?
| | Campylobacter jejuni | 1 | 2008 | 16 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 4293 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 1031 | 0.020 |
Why?
| | Viral Load | 1 | 2010 | 526 | 0.020 |
Why?
| | Gene Expression | 1 | 1992 | 1490 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1994 | 1129 | 0.020 |
Why?
| | Promoter Regions, Genetic | 2 | 1994 | 1258 | 0.020 |
Why?
| | User-Computer Interface | 1 | 2008 | 165 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2009 | 356 | 0.020 |
Why?
| | Phosphines | 1 | 1986 | 18 | 0.020 |
Why?
| | Orexins | 1 | 2006 | 6 | 0.020 |
Why?
| | Huntingtin Protein | 1 | 2006 | 13 | 0.020 |
Why?
| | Sequence Homology | 1 | 2006 | 43 | 0.020 |
Why?
| | Enterobactin | 1 | 1986 | 8 | 0.020 |
Why?
| | Oligopeptides | 1 | 1988 | 269 | 0.010 |
Why?
| | DNA Restriction Enzymes | 1 | 2005 | 53 | 0.010 |
Why?
| | Protein Conformation | 1 | 1989 | 946 | 0.010 |
Why?
| | Decision Making | 1 | 2013 | 980 | 0.010 |
Why?
| | Serine | 1 | 1986 | 145 | 0.010 |
Why?
| | Organometallic Compounds | 1 | 1986 | 112 | 0.010 |
Why?
| | Databases, Nucleic Acid | 1 | 2005 | 39 | 0.010 |
Why?
| | Housing | 1 | 2006 | 144 | 0.010 |
Why?
| | Automation | 1 | 2005 | 102 | 0.010 |
Why?
| | Molecular Structure | 2 | 1996 | 501 | 0.010 |
Why?
| | Tandem Repeat Sequences | 1 | 2004 | 22 | 0.010 |
Why?
| | Fourier Analysis | 1 | 2004 | 41 | 0.010 |
Why?
| | Ovary | 1 | 1986 | 228 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2017 | 6053 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 1986 | 377 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2118 | 0.010 |
Why?
| | Fibroblasts | 1 | 1989 | 1034 | 0.010 |
Why?
| | Signal Recognition Particle | 1 | 2002 | 9 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1994 | 66 | 0.010 |
Why?
| | Ferritins | 1 | 2002 | 69 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5417 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 592 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2006 | 672 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2001 | 12 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 881 | 0.010 |
Why?
| | Copper | 2 | 1994 | 113 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2006 | 749 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2001 | 152 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2185 | 0.010 |
Why?
| | Aminoglycosides | 1 | 1999 | 29 | 0.010 |
Why?
| | Pilot Projects | 1 | 2005 | 1890 | 0.010 |
Why?
| | Risk Factors | 1 | 2014 | 10792 | 0.010 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 1999 | 40 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 2 | 1994 | 477 | 0.010 |
Why?
| | Ubiquitin-Activating Enzymes | 2 | 1989 | 20 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2006 | 3608 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3550 | 0.010 |
Why?
| | Postoperative Period | 1 | 1999 | 354 | 0.010 |
Why?
| | Mice, SCID | 1 | 1998 | 369 | 0.010 |
Why?
| | Ligands | 1 | 1999 | 674 | 0.010 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 1989 | 193 | 0.010 |
Why?
| | Coronary Artery Bypass | 1 | 1999 | 269 | 0.010 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1998 | 235 | 0.010 |
Why?
| | Phospholipases A2 | 1 | 1996 | 79 | 0.010 |
Why?
| | Cadmium | 2 | 1987 | 69 | 0.010 |
Why?
| | Cricetinae | 2 | 1987 | 304 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 166 | 0.010 |
Why?
| | Gold | 2 | 1986 | 116 | 0.010 |
Why?
| | Transducin | 1 | 1994 | 42 | 0.010 |
Why?
| | Biomarkers | 1 | 2006 | 4275 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1994 | 101 | 0.010 |
Why?
| | RNA, Fungal | 1 | 1994 | 73 | 0.010 |
Why?
| | Mercaptoethanol | 1 | 1993 | 9 | 0.010 |
Why?
| | Methods | 1 | 1993 | 69 | 0.010 |
Why?
| | Cell Survival | 2 | 1987 | 1098 | 0.010 |
Why?
| | Circular Dichroism | 1 | 1993 | 150 | 0.010 |
Why?
| | Bovine papillomavirus 1 | 1 | 1992 | 1 | 0.010 |
Why?
| | Luciferases | 1 | 1992 | 152 | 0.010 |
Why?
| | Codon | 1 | 1992 | 94 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1992 | 138 | 0.010 |
Why?
| | Lysine | 1 | 1994 | 302 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1993 | 919 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 1992 | 178 | 0.010 |
Why?
| | Cytokines | 1 | 1999 | 2065 | 0.010 |
Why?
| | Cell Membrane | 1 | 1994 | 706 | 0.010 |
Why?
| | Chromosome Deletion | 1 | 1990 | 124 | 0.000 |
Why?
| | T-Lymphocytes | 1 | 1998 | 1982 | 0.000 |
Why?
| | Butyric Acid | 1 | 1989 | 6 | 0.000 |
Why?
| | Phorbol 12,13-Dibutyrate | 1 | 1989 | 8 | 0.000 |
Why?
| | Electrophoresis | 1 | 1989 | 31 | 0.000 |
Why?
| | Chromatography, Ion Exchange | 1 | 1989 | 57 | 0.000 |
Why?
| | Copper Sulfate | 1 | 1988 | 8 | 0.000 |
Why?
| | Methylation | 1 | 1989 | 242 | 0.000 |
Why?
| | Substrate Specificity | 1 | 1989 | 392 | 0.000 |
Why?
| | Butyrates | 1 | 1989 | 67 | 0.000 |
Why?
| | Membrane Proteins | 1 | 1994 | 1167 | 0.000 |
Why?
| | Retrospective Studies | 1 | 2006 | 17101 | 0.000 |
Why?
| | Hydrolysis | 1 | 1988 | 199 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4569 | 0.000 |
Why?
| | Organogold Compounds | 1 | 1986 | 5 | 0.000 |
Why?
| | Dexamethasone | 1 | 1989 | 372 | 0.000 |
Why?
| | Cell Compartmentation | 1 | 1986 | 54 | 0.000 |
Why?
| | Cricetulus | 1 | 1986 | 118 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1986 | 167 | 0.000 |
Why?
| | Drug Resistance | 1 | 1987 | 153 | 0.000 |
Why?
| | Albumins | 1 | 1986 | 118 | 0.000 |
Why?
| | Spectrum Analysis | 1 | 1986 | 93 | 0.000 |
Why?
| | Tissue Distribution | 1 | 1986 | 334 | 0.000 |
Why?
| | Adenosine Triphosphate | 1 | 1988 | 498 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1986 | 561 | 0.000 |
Why?
| | Sulfhydryl Compounds | 1 | 1986 | 189 | 0.000 |
Why?
| | Amino Acids | 1 | 1987 | 522 | 0.000 |
Why?
| | Polymers | 1 | 1987 | 499 | 0.000 |
Why?
| | Zinc | 1 | 1986 | 295 | 0.000 |
Why?
| | Carrier Proteins | 1 | 1986 | 737 | 0.000 |
Why?
| | Proteins | 1 | 1986 | 1022 | 0.000 |
Why?
|
|
Ecker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|